211 related articles for article (PubMed ID: 29751042)
21. Clinicopathologic study of 10 cases of gastric adenocarcinoma with hepatoid or enteroblastic differentiation.
Kuroda N; Yorita K
Pol J Pathol; 2018; 69(2):128-135. PubMed ID: 30351859
[TBL] [Abstract][Full Text] [Related]
22. Two cases of gastric adenocarcinoma with enteroblastic differentiation resected by endoscopic submucosal dissection.
Kato T; Hikichi T; Nakamura J; Takasumi M; Hashimoto M; Kobashi R; Takagi T; Suzuki R; Sugimoto M; Sato Y; Okubo Y; Satake S; Oka Y; Yamada S; Kobayakawa M; Hashimoto Y; Ohira H
Clin J Gastroenterol; 2021 Jun; 14(3):736-744. PubMed ID: 33629257
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.
Chen H; Ye Q; Lv J; Ye P; Sun Y; Fan S; Su X; Gavine P; Yin X
Pathol Oncol Res; 2015 Sep; 21(4):947-55. PubMed ID: 25749810
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological features of rectal adenocarcinoma with enteroblastic differentiation].
Liu J; Liu XL; Lin DL; Zhao H; Li YJ; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):797-801. PubMed ID: 37527983
[No Abstract] [Full Text] [Related]
25. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
26. Gastric adenocarcinoma with enteroblastic differentiation followed endoscopically: A case report.
Kimura T; Hikichi T; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Takagi T; Suzuki R; Sugimoto M; Sato Y; Irie H; Saze Z; Kobayakawa M; Kono K; Ohira H
Clin J Gastroenterol; 2020 Dec; 13(6):1074-1082. PubMed ID: 32875425
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Matsumoto K; Ueyama H; Matsumoto K; Akazawa Y; Komori H; Takeda T; Murakami T; Asaoka D; Hojo M; Tomita N; Nagahara A; Kajiyama Y; Yao T; Watanabe S
World J Gastroenterol; 2016 Sep; 22(36):8203-10. PubMed ID: 27688662
[TBL] [Abstract][Full Text] [Related]
28. Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.
Cenaj O; Ligon AH; Hornick JL; Sholl LM
Am J Clin Pathol; 2019 Jun; 152(1):97-108. PubMed ID: 31115453
[TBL] [Abstract][Full Text] [Related]
29. Sustained Clinical Complete Response after Discontinuation of Trastuzumab-deruxetecan Due to Interstitial Pneumonia for HER2-positive Gastric adenocarcinoma with Enteroblastic Differentiation (GAED): A Case Report.
Suzuki N; Odawara N; Fujisawa G; Ishibashi R; Hata M; Oya Y; Tamada K; Hayashi T; Abe S; Miyakawa Y; Hayakawa Y; Shinozaki-Ushiku A; Ushiku T; Boku N; Fujishiro M
Intern Med; 2024 Jun; ():. PubMed ID: 38839335
[TBL] [Abstract][Full Text] [Related]
30. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
31. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
32. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
Yoshida T; Yamaguchi T; Maekawa S; Takano S; Kuno T; Tanaka K; Iwamoto F; Tsukui Y; Kobayashi S; Asakawa Y; Shindo H; Fukasawa M; Nakayama Y; Inoue T; Uetake T; Ohtaka M; Sato T; Mochizuki K; Enomoto N
Gastric Cancer; 2019 Jul; 22(4):742-750. PubMed ID: 30756200
[TBL] [Abstract][Full Text] [Related]
33. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.
Wang Y; Sun L; Li Z; Gao J; Ge S; Zhang C; Yuan J; Wang X; Li J; Lu Z; Gong J; Lu M; Zhou J; Peng Z; Shen L; Zhang X
Gastric Cancer; 2019 Nov; 22(6):1183-1192. PubMed ID: 30989433
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Chmielecki J; Ross JS; Wang K; Frampton GM; Palmer GA; Ali SM; Palma N; Morosini D; Miller VA; Yelensky R; Lipson D; Stephens PJ
Oncologist; 2015 Jan; 20(1):7-12. PubMed ID: 25480824
[TBL] [Abstract][Full Text] [Related]
35. Yolk Sac Tumor Originating From Cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
[TBL] [Abstract][Full Text] [Related]
36. Ureteral Metastasis of Colonic Adenocarcinoma with Enteroblastic Differentiation: A Rare Case to be Distinguished from Clear Cell Adenocarcinoma of the Urinary Tract.
Minato H; Yoshikawa A; Tsuyama S; Katayanagi K; Hayashi K; Sakimura Y; Bando H; Hori T; Kito Y
Int J Surg Pathol; 2023 Dec; 31(8):1553-1558. PubMed ID: 36895103
[TBL] [Abstract][Full Text] [Related]
37. Ampullary Carcinosarcoma with Enteroblastic Differentiation: A Case Report.
Haider MA; Naqvi S; Barakat O; Wilken SE; Dhingra S
Ann Clin Lab Sci; 2021 Jan; 51(1):131-135. PubMed ID: 33653792
[TBL] [Abstract][Full Text] [Related]
38. Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
Hedner C; Tran L; Borg D; Nodin B; Jirström K; Eberhard J
Histopathology; 2016 Jan; 68(2):230-40. PubMed ID: 26016514
[TBL] [Abstract][Full Text] [Related]
39. Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Gushima R; Narita R; Shono T; Naoe H; Yao T; Sasaki Y
J Gastrointestin Liver Dis; 2017 Jun; 26(2):193-197. PubMed ID: 28617891
[TBL] [Abstract][Full Text] [Related]
40. HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
Liu Z; Shi M; Li X; Song S; Liu N; Du H; Ye J; Li H; Zhang Z; Zhang L
J Cancer Res Clin Oncol; 2021 May; 147(5):1315-1324. PubMed ID: 33543328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
